The Digital Transformation In Radiology

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

On this episode of I Don’t Care, Host Kevin Stevenson talked with Dr. Moira Scheike, Founder of Cubismi and a board-certified radiologist specializing in cancer imaging. She invented 5D medical imaging technology. Cubismi is an interactive digital diagnostics pioneer who personalizes actionable visualizations and precision insights to transform and empower each professional interaction and patient journey. The duo talked about the cause and effect of the decline in the radiology job market, and how it can be reversed, and 5D imaging technology.

When it comes to imaging, the practice of radiology relies on outdated technology. When it comes to the digital transformation in radiology, 90 percent of the data is imaging. The industry also hasn’t benefitted from a digital transformation, which has left it open to high error rates and failures in disease detection. Schieke believes the field is poised for innovation and investment, both of which she argues is vital for rejuvenating the sector.

“We can think about it from two angles: what can we do about in the here and now, and immediately to address what are our major pains for the radiologist and healthcare systems dealing with huge problems around diagnostics,” Scheike said. “…in the long term, the big long term view, is we all know we have this vision for the future, a precision medicine future.”

The technological future Scheike refers to involves cloud computing and artificial intelligence. The challenges lie in stepping through and dealing with the current problems and then getting into the future. Another major problem is that the radiology job market is declining, with little investment being directed into the field over the past decade.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More